US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

250.41

+0.01000.00%

Post-market: 251.701.29+0.52%18:51 EDT

Volume:215.52K

Turnover:54.53M

Market Cap:494.43M

PE:- -

High:259.83

Open:253.12

Low:242.96

Close:250.40

52wk High:341.93

52wk Low:76.29

Shares:1.97M

Float Shares:1.97M

Volume Ratio:0.82

T/O Rate:10.92%

Dividend:1.00

Dividend Rate:0.40%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

EBR Systems Says US FDA Begins Pre-Approval Inspection of California Manufacturing Facility

MT Newswires Live

FDA begins pre-approval inspection of EBR Systems’ new cardiac device plant

Flexible Workers Urged to Join Employee Medical Insurance as China's Gig Workforce Surpasses 200 Million

Flexible Workers Encouraged to Enroll in Employee Medical Insurance as National Flexible Workforce Tops 200 Million

Wall Street Analysts Are Bullish on Top Real Estate Picks

CurveBeam AI Wins FDA Clearance for CT-Based Bone Density Platform

Health Care up on Rotation into Less Fuel-Sensitive Sectors

Analysts Are Bullish on Top Healthcare Stocks: Revolution Medicines (RVMD), ArriVent BioPharma, Inc. (AVBP)

Revolution Medicines Gets US FDA Breakthrough Therapy Designation for Rasonque To Treat Pancreatic Cancer

MT Newswires Live

60 Degrees Advances Babesiosis Treatment With FDA Submission

Revolution Medicines granted Breakthrough Therapy Designation to Rasonque by FDA

Healthcare Services management to meet with Oppenheimer

Analysts’ Top Healthcare Picks: Corbus Pharmaceuticals (CRBP), Definium Therapeutics (DFTX)

Eton Pharmaceuticals participates in a conference call with Craig-Hallum

Ultragenyx treatment of GNE myopathy granted orphan designation

Analysts Offer Insights on Healthcare Companies: Acadia Healthcare (ACHC) and Zentek (OtherZTEKF)

Analysts Offer Insights on Healthcare Companies: Addus Homecare (ADUS) and Cardiff Oncology (CRDF)

Biofrontera Gains FDA Approval for Ameluz Skin Cancer Use

Unicycive Therapeutics Faces Securities Lawsuit After 39% Stock Plunge Over Repeat FDA Manufacturing Setback

Biofrontera announces FDA approval of Ameluz supplemental new drug application

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/stock/LABU/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":250.41,"timestamp":1789588800000,"preClose":250.4,"halted":0,"volume":215519,"hourTrading":{"tag":"盘后","latestPrice":251.7,"preClose":250.41,"latestTime":"18:51 EDT","volume":749,"amount":187670.87808,"timestamp":1789599119897,"change":1.29,"changeRate":0.005152,"amplitude":0.006869},"delay":0,"changeRate":0.000039936102236385406,"floatShares":1974486,"shares":1974486,"eps":0,"marketStatus":"Post-Mkt","change":0.01,"latestTime":"09-16 18:53:56 EDT","open":253.12,"high":259.83,"low":242.96,"amount":54533285.505219996,"amplitude":0.067372,"askPrice":252.5,"askSize":1,"bidPrice":250.41,"bidSize":400,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1789603200000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":250.4,"sharesOutstanding":3074486,"nav":268.659,"aum":530464172.89,"dividendRate":0.004,"bidAskSpread":0.003539,"preHourTrading":{"tag":"盘前","latestPrice":254.8128,"preClose":250.4,"latestTime":"09:28 EDT","volume":4289,"amount":1082884.5326099999,"timestamp":1789565312693,"change":4.4128,"changeRate":0.017623,"amplitude":0.012511},"postHourTrading":{"tag":"盘后","latestPrice":251.7,"preClose":250.41,"latestTime":"18:51 EDT","volume":749,"amount":187670.87808,"timestamp":1789599119897,"change":1.29,"changeRate":0.005152,"amplitude":0.006869},"volumeRatio":0.824727,"impliedVol":0.9487,"impliedVolPercentile":0.6773},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":1974486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.824727,"shares":1974486,"dividePrice":1.0016,"high":259.83,"amplitude":0.067372,"preClose":250.4,"low":242.96,"week52Low":76.29,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":250.41,"committee":0.995012,"eps":0,"divideRate":0.004,"volume":215519,"delay":0,"ttmEps":0,"open":253.12,"prevYearClose":159.39,"prevWeekClose":261.3,"prevMonthClose":296.31,"prevQuarterClose":292.1,"fiveDayClose":279.02,"twentyDayClose":289.98,"sixtyDayClose":230.01},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2667691420","title":"EBR Systems Says US FDA Begins Pre-Approval Inspection of California Manufacturing Facility","url":"https://stock-news.laohu8.com/highlight/detail?id=2667691420","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667691420?lang=en_us&edition=fundamental","pubTime":"2026-09-15 07:56","pubTimestamp":1789430215,"startTime":"0","endTime":"0","summary":"EBR Systems  said the US Food and Drug Administration  started its pre-approval inspection of the company's new manufacturing facility in Santa Clara, California, marking a key step in the regulatory process, according to a Tuesday filing with the Australian bourse.The company still anticipates receiving US FDA approval for the facility by the end of the year, the filing added.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","EBR.AU","LABU","BK7007","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667691207","title":"FDA begins pre-approval inspection of EBR Systems’ new cardiac device plant","url":"https://stock-news.laohu8.com/highlight/detail?id=2667691207","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667691207?lang=en_us&edition=fundamental","pubTime":"2026-09-15 07:53","pubTimestamp":1789429998,"startTime":"0","endTime":"0","summary":"The latest announcement is out from EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh ( ($AU:EBR) ). EBR Systems, Inc., developer of the w...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/fda-begins-pre-approval-inspection-of-ebr-systems-new-cardiac-device-plant?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/fda-begins-pre-approval-inspection-of-ebr-systems-new-cardiac-device-plant?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LABU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129994098","title":"Flexible Workers Urged to Join Employee Medical Insurance as China's Gig Workforce Surpasses 200 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1129994098","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1129994098?lang=en_us&edition=fundamental","pubTime":"2026-09-15 07:50","pubTimestamp":1789429829,"startTime":"0","endTime":"0","summary":"China's legislative authority has taken a significant step to broaden healthcare coverage for its expanding gig economy workforce. The Standing Committee of the 14th National People's Congress passed...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","XLV","LABU","BK4581","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145552199","title":"Flexible Workers Encouraged to Enroll in Employee Medical Insurance as National Flexible Workforce Tops 200 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1145552199","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1145552199?lang=en_us&edition=fundamental","pubTime":"2026-09-15 07:40","pubTimestamp":1789429229,"startTime":"0","endTime":"0","summary":"A new legal provision is set to encourage self-employed individuals without hired staff, part-time workers not covered by employer-based employee basic medical insurance, and other flexible workers...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4581","XLV","BK4585","LABU","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667691769","title":"Wall Street Analysts Are Bullish on Top Real Estate Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2667691769","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667691769?lang=en_us&edition=fundamental","pubTime":"2026-09-15 07:40","pubTimestamp":1789429205,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Real Estate sector as 2 analysts just weighed in on American Healthcare REIT, Inc. (AHR) and GPT Group ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-real-estate-picks-blurbs-news-39?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-real-estate-picks-blurbs-news-39?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","YLDW","BK4225","IVRA","LABU","REIT","PSCF","RJMG","BK4585","XLV","DFRA","BK4588","GPT","BPRE","AHR","BK4581","IQRA","MDIV","RNTY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667699733","title":"CurveBeam AI Wins FDA Clearance for CT-Based Bone Density Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2667699733","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667699733?lang=en_us&edition=fundamental","pubTime":"2026-09-15 06:45","pubTimestamp":1789425907,"startTime":"0","endTime":"0","summary":"Curvebeam AI Ltd. ( ($AU:CVB) ) has provided an update. CurveBeam AI has secured U.S. FDA 510(k) clearance for its CT-based bone mineral density te...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/curvebeam-ai-wins-fda-clearance-for-ct-based-bone-density-platform?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/curvebeam-ai-wins-fda-clearance-for-ct-based-bone-density-platform?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["QTOC","VTHR","AGIX","BK4588","BK4585","LABU","AIPO","CHAT","ARTY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667696065","title":"Health Care up on Rotation into Less Fuel-Sensitive Sectors","url":"https://stock-news.laohu8.com/highlight/detail?id=2667696065","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667696065?lang=en_us&edition=fundamental","pubTime":"2026-09-15 06:05","pubTimestamp":1789423500,"startTime":"0","endTime":"0","summary":"Health-care companies rose as traders rotated into sectors less susceptible to rising fuel prices and interest rates.Wegovy maker Novo Nordisk plans to rebrand itself as Novo, betting a shorter name will help it resonate more with consumers as it competes with rival Eli Lilly.AstraZeneca said its new breast-cancer pill missed the key goal of slowing the disease from worsening in a late-stage clinical trial. Shares of the British drug maker still gained.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","BK4581","BK4588","BK4585","LABU","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667966776","title":"Analysts Are Bullish on Top Healthcare Stocks: Revolution Medicines (RVMD), ArriVent BioPharma, Inc. (AVBP)","url":"https://stock-news.laohu8.com/highlight/detail?id=2667966776","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667966776?lang=en_us&edition=fundamental","pubTime":"2026-09-15 05:10","pubTimestamp":1789420212,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Revolution Medicines (RVMD) and ArriVent BioPharma, ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-revolution-medicines-rvmd-arrivent-biopharma-inc-avbp-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-revolution-medicines-rvmd-arrivent-biopharma-inc-avbp-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD","LU0320765992.SGD","IE0002141913.USD","CANC","XBI","PTH","BK4581","AVBP","BBH","IE0009354923.USD","RVMD","LU0109394709.USD","LABU","BK4588","IE00BJT1NW94.SGD","XLV","BK4139","IDNA","IE00B4R5TH58.HKD","LU0029874061.USD","LU0128526141.USD","HCSG","LU0889565916.HKD","IE00B2B36J28.USD","BK4137","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667695932","title":"Revolution Medicines Gets US FDA Breakthrough Therapy Designation for Rasonque To Treat Pancreatic Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2667695932","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667695932?lang=en_us&edition=fundamental","pubTime":"2026-09-15 04:35","pubTimestamp":1789418122,"startTime":"0","endTime":"0","summary":"Revolution Medicines  said Monday that the US Food and Drug Administration has given breakthrough therapy designation to Rasonque plus chemotherapy to treat pancreatic cancer.The company said Rasonque was recently approved by the US FDA to treat adults with metastatic pancreatic cancer who have received at least one systemic therapy or who are not candidates for multiagent systemic therapy.Revolution said the use of Rasonque plus chemotherapy for treatment-naive metastatic pancreatic adenocarcinoma is still investigational, with safety and efficacy not yet established.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD","LU0320765992.SGD","IE0002141913.USD","CANC","PTH","BBH","IE0009354923.USD","RVMD","LU0109394709.USD","LABU","BK4588","IE00BJT1NW94.SGD","BK4139","IDNA","IE00B4R5TH58.HKD","LU0889565916.HKD","IE00B2B36J28.USD","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667169544","title":"60 Degrees Advances Babesiosis Treatment With FDA Submission","url":"https://stock-news.laohu8.com/highlight/detail?id=2667169544","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667169544?lang=en_us&edition=fundamental","pubTime":"2026-09-15 04:32","pubTimestamp":1789417923,"startTime":"0","endTime":"0","summary":"60 Degrees Pharmaceuticals, Inc. ( ($SXTP) ) just unveiled an announcement. On September 12, 2026, 60 Degrees Pharmaceuticals submitted a Statement...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/60-degrees-advances-babesiosis-treatment-with-fda-submission?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/60-degrees-advances-babesiosis-treatment-with-fda-submission?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4585","LABU","SXTP","PRTO","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667953426","title":"Revolution Medicines granted Breakthrough Therapy Designation to Rasonque by FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2667953426","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667953426?lang=en_us&edition=fundamental","pubTime":"2026-09-15 04:15","pubTimestamp":1789416936,"startTime":"0","endTime":"0","summary":"Revolution Medicines (RVMD) announced that the FDA has granted Breakthrough Therapy Designation to Rasonque, the company’s RAS multi-selective inhi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/revolution-medicines-granted-breakthrough-therapy-designation-to-rasonque-by-fda-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/revolution-medicines-granted-breakthrough-therapy-designation-to-rasonque-by-fda-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CANC","RVMD","LU0889565916.HKD","BK4588","LU0320765992.SGD","IDNA","PTH","BK4139","IE0009354923.USD","IE0002141913.USD","IE00B4R5TH58.HKD","IE0009355771.USD","LU0109394709.USD","IE00BJT1NW94.SGD","BBH","IE00BFTCPJ56.SGD","BK4585","LABU","IE00B2B36J28.USD","IE00BJJMRZ35.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667698712","title":"Healthcare Services management to meet with Oppenheimer","url":"https://stock-news.laohu8.com/highlight/detail?id=2667698712","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667698712?lang=en_us&edition=fundamental","pubTime":"2026-09-15 03:00","pubTimestamp":1789412410,"startTime":"0","endTime":"0","summary":"Meeting to be held in New York on September 22 and in Boston on September 23 hosted by Oppenheimer. Published first on TheFly – the ultimate source...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/healthcare-services-management-to-meet-with-oppenheimer-thefly-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/healthcare-services-management-to-meet-with-oppenheimer-thefly-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","XBI","HCSG","BK4581","LABU","LU0128526141.USD","BK4137","BK4585","XLV","LU0029874061.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667667409","title":"Analysts’ Top Healthcare Picks: Corbus Pharmaceuticals (CRBP), Definium Therapeutics (DFTX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2667667409","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667667409?lang=en_us&edition=fundamental","pubTime":"2026-09-15 00:10","pubTimestamp":1789402226,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Corbus Pharmaceuticals (CRBP) and Definium Therapeut...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-corbus-pharmaceuticals-crbp-definium-therapeutics-dftx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-corbus-pharmaceuticals-crbp-definium-therapeutics-dftx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","HCSG","BK4139","XBI","BK4137","DFTX","BK4007","LU0128526141.USD","CRBP","BK4585","LU0029874061.USD","XLV","BK4588","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667673746","title":"Eton Pharmaceuticals participates in a conference call with Craig-Hallum","url":"https://stock-news.laohu8.com/highlight/detail?id=2667673746","media":"TIPRANKS","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667673746?lang=en_us&edition=fundamental","pubTime":"2026-09-15 00:00","pubTimestamp":1789401633,"startTime":"0","endTime":"0","summary":"Healthcare Analyst Hewitt holds a conference call with President & CEO Stephen Gunstream on September 16 at 2 pm hosted by Craig-Hallum. Webcast Li...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/eton-pharmaceuticals-participates-in-a-conference-call-with-craig-hallum-thefly-news-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/eton-pharmaceuticals-participates-in-a-conference-call-with-craig-hallum-thefly-news-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","BK4581","BK4588","BK4585","LABU","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667673226","title":"Ultragenyx treatment of GNE myopathy granted orphan designation","url":"https://stock-news.laohu8.com/highlight/detail?id=2667673226","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667673226?lang=en_us&edition=fundamental","pubTime":"2026-09-15 00:00","pubTimestamp":1789401611,"startTime":"0","endTime":"0","summary":"Ultragenyx (RARE) Pharmaceutical was granted FDA orphan designation for a treatment of GNE myopathy, according to a post to the agency’s website. P...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ultragenyx-treatment-of-gne-myopathy-granted-orphan-designation-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ultragenyx-treatment-of-gne-myopathy-granted-orphan-designation-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","GNE","BK4139","BK4585","RARE","BK4588","BK4081"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667066737","title":"Analysts Offer Insights on Healthcare Companies: Acadia Healthcare (ACHC) and Zentek (OtherZTEKF)","url":"https://stock-news.laohu8.com/highlight/detail?id=2667066737","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667066737?lang=en_us&edition=fundamental","pubTime":"2026-09-14 23:50","pubTimestamp":1789401007,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Acadia Healthcare (ACHC) and Zentek (ZTEKF). Acadia Healthcare (A...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-acadia-healthcare-achc-and-zentek-otherztekf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-acadia-healthcare-achc-and-zentek-otherztekf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4588","BK4581","XBI","BK4185","ZTEKF","BK4198","ACHC","XLV","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667662788","title":"Analysts Offer Insights on Healthcare Companies: Addus Homecare (ADUS) and Cardiff Oncology (CRDF)","url":"https://stock-news.laohu8.com/highlight/detail?id=2667662788","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667662788?lang=en_us&edition=fundamental","pubTime":"2026-09-14 23:30","pubTimestamp":1789399820,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Addus Homecare (ADUS) and Cardiff Oncology (CRDF)....","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-addus-homecare-adus-and-cardiff-oncology-crdf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-addus-homecare-adus-and-cardiff-oncology-crdf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","ADUS","IE00BN0W2V16.EUR","BK4585","BK4581","HCSG","LABU","XLV","LU0128526141.USD","IE00BN0W2T93.GBP","CRDF","IE00BN0W2W23.USD","BK4137","BK4139","LU0029874061.USD","BK4196","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667271661","title":"Biofrontera Gains FDA Approval for Ameluz Skin Cancer Use","url":"https://stock-news.laohu8.com/highlight/detail?id=2667271661","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667271661?lang=en_us&edition=fundamental","pubTime":"2026-09-14 21:58","pubTimestamp":1789394295,"startTime":"0","endTime":"0","summary":"Biofrontera ( ($BFRI) ) has provided an announcement. On September 14, 2026, Biofrontera announced that the U.S. Food and Drug Administration appro...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/biofrontera-gains-fda-approval-for-ameluz-skin-cancer-use?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/biofrontera-gains-fda-approval-for-ameluz-skin-cancer-use?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4585","BK4588","BFRI","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667866173","title":"Unicycive Therapeutics Faces Securities Lawsuit After 39% Stock Plunge Over Repeat FDA Manufacturing Setback","url":"https://stock-news.laohu8.com/highlight/detail?id=2667866173","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667866173?lang=en_us&edition=fundamental","pubTime":"2026-09-14 21:44","pubTimestamp":1789393468,"startTime":"0","endTime":"0","summary":"Unicycive Therapeutics, Inc. ($UNCY) is facing a federal securities lawsuit after its shares fell sharply following news that the FDA had issued a ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/class-action/unicycive-therapeutics-faces-securities-lawsuit-after-39-stock-plunge-over-repeat-fda-manufacturing-setback?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/class-action/unicycive-therapeutics-faces-securities-lawsuit-after-39-stock-plunge-over-repeat-fda-manufacturing-setback?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","UNCY","BK4139","LABU","BK4539","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667661630","title":"Biofrontera announces FDA approval of Ameluz supplemental new drug application","url":"https://stock-news.laohu8.com/highlight/detail?id=2667661630","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667661630?lang=en_us&edition=fundamental","pubTime":"2026-09-14 21:35","pubTimestamp":1789392922,"startTime":"0","endTime":"0","summary":"Biofrontera (BFRI) announced that the FDA has approved the company’s supplemental new drug application, or sNDA, for Ameluz topical gel, 10%, in co...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/biofrontera-announces-fda-approval-of-ameluz-supplemental-new-drug-application-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/biofrontera-announces-fda-approval-of-ameluz-supplemental-new-drug-application-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MEDI","MRNY","IEIH","LABU","GNMX","TECB","IYH","GDOC","BK4007","PSCH","PINK","SYNB","BFRI","NVIB","LFSC","BMED","TBXU","IDNA","BK4585","BBP","MRNX","XLVX","RSPH","BK4588","FRTY","IBB"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":21,"pageCount":5,"totalSize":413,"code":"91000000","status":"200"}]}}